Reset Map5 Results
900 Ridgebury Road R&D 7313 Ridgefield, Connecticut, 06877 United StatesWe are experts in developing in vitro 3D Human-derived Adipose Tissue and Heart Spheroids and Organoids. Our 3D human models are self-assembled and Matrigel-free, setting us apart from our competitors. Our 3D human models are morpho-functionally validated compared to classic 2D models widespread in drug discovery and development. In addition, we provide consulting in 3D technologies and confocal and high throughput microscope imaging focused on morphological and functional characterization of 3D models. OUR PORTFOLIO FOR ADIPOSE TISSUE INCLUDES: - Models derived from human adult cells. Stromal vascular fraction, SFV of both subcutaneous and visceral fat depots, the latter an exclusive product that sets us apart in the market. - Bonds Bio 3D human Adipose Tissue organoids in the most advanced platform to access mitochondrial respiration (OCR) and glycolysis (ECAR) (3D Seahorse plates - Seahorse, Agilent) ready to treat and read. - 2D-to-3D transition kits containing 96-well plates with 3D progenitor organoids and 96-well plates with 2D progenitor cells in a monolayer to run Bonds Bio Adipose Tissue differentiation protocol in parallel (Subcutaneous or Visceral). This transition kit is for you who need an extra layer of confidence before a complete transition to Bonds Bio 3D human mature organoids. We provide our organoids in 96- and 384-well plates, with individual organoids per well, an outstanding source of unique feature samples for your testing, allowing for mid-to-large scale analysis and compatible with the most common high-throughput systems available in the market. Our models are validated using cells from healthy donors (commercially available now) and Patient-Derived Organoids (PDOs) with samples from different ages, races, BMI index, and diseases (e.g., Type 2 diabetes, cancers). (For more information on our PDO line, contact us). COMING SOON… In addition to the human adult SVF-derived adipose tissue models, we are developing outstanding Adipose Tissue and Heart 3D human models derived from human-induced pluripotent stem cells (hiPSCs). We are now differentiating hiPSCs into subcutaneous, visceral, and beige-like adipocytes to assemble the next generation of Bonds Bio 3D human Adipose Tissue Organoids from hiPSCs. Last but not least, very soon, we will launch our hiPSC-derived Heart spheroids and Heart Organoids for you to test drugs cardiotoxicity and cardiovascular diseases in two outstanding platforms, more sensitive than their 2D peers and less complicated to handle than engineered-heart tissues (EHTs). Your heart will "beat faster" with Bonds Bio 3D Heart models (For more information on our Cardio line, contact us). ABOUT OUR COMPANY The development of human physiologically relevant 3D organoids is made more accessible with Bonds Biosystems. Our Mission is to turn INNOVATIVE science into more accurate and affordable therapies for patients worldwide through In VITRO 3D solutions, envisioning the creation of technologies that accelerate drug development, enhancing new therapies' efficacy to bring new HOPES to humankind, preferably reducing costs and reducing or even avoiding the need for animal models use. If you want to be a part of this revolution of in vitro biology, do not hesitate to contact us at bondsbio.com/contact We are looking forward to helping you to transform your 3D experience!
27 Strathmore Road attn. Bonds Biosystems Natick, 01760 United StatesWe are experts in developing in vitro 3D Human-derived Adipose Tissue and Heart Spheroids and Organoids. Our 3D human models are self-assembled and Matrigel-free, setting us apart from our competitors. Our 3D human models are morpho-functionally validated compared to classic 2D models widespread in drug discovery and development. In addition, we provide consulting in 3D technologies and confocal and high throughput microscope imaging focused on morphological and functional characterization of 3D models. OUR PORTFOLIO FOR ADIPOSE TISSUE INCLUDES: - Models derived from human adult cells. Stromal vascular fraction, SFV of both subcutaneous and visceral fat depots, the latter an exclusive product that sets us apart in the market. - Bonds Bio 3D human Adipose Tissue organoids in the most advanced platform to access mitochondrial respiration (OCR) and glycolysis (ECAR) (3D Seahorse plates - Seahorse, Agilent) ready to treat and read. - 2D-to-3D transition kits containing 96-well plates with 3D progenitor organoids and 96-well plates with 2D progenitor cells in a monolayer to run Bonds Bio Adipose Tissue differentiation protocol in parallel (Subcutaneous or Visceral). This transition kit is for you who need an extra layer of confidence before a complete transition to Bonds Bio 3D human mature organoids. We provide our organoids in 96- and 384-well plates, with individual organoids per well, an outstanding source of unique feature samples for your testing, allowing for mid-to-large scale analysis and compatible with the most common high-throughput systems available in the market. Our models are validated using cells from healthy donors (commercially available now) and Patient-Derived Organoids (PDOs) with samples from different ages, races, BMI index, and diseases (e.g., Type 2 diabetes, cancers). (For more information on our PDO line, contact us). COMING SOON… In addition to the human adult SVF-derived adipose tissue models, we are developing outstanding Adipose Tissue and Heart 3D human models derived from human-induced pluripotent stem cells (hiPSCs). We are now differentiating hiPSCs into subcutaneous, visceral, and beige-like adipocytes to assemble the next generation of Bonds Bio 3D human Adipose Tissue Organoids from hiPSCs. Last but not least, very soon, we will launch our hiPSC-derived Heart spheroids and Heart Organoids for you to test drugs cardiotoxicity and cardiovascular diseases in two outstanding platforms, more sensitive than their 2D peers and less complicated to handle than engineered-heart tissues (EHTs). Your heart will "beat faster" with Bonds Bio 3D Heart models (For more information on our Cardio line, contact us). ABOUT OUR COMPANY The development of human physiologically relevant 3D organoids is made more accessible with Bonds Biosystems. Our Mission is to turn INNOVATIVE science into more accurate and affordable therapies for patients worldwide through In VITRO 3D solutions, envisioning the creation of technologies that accelerate drug development, enhancing new therapies' efficacy to bring new HOPES to humankind, preferably reducing costs and reducing or even avoiding the need for animal models use. If you want to be a part of this revolution of in vitro biology, do not hesitate to contact us at bondsbio.com/contact We are looking forward to helping you to transform your 3D experience!
27 Strathmore Road attn. Bonds Biosystems Natick, MA, 01760 United StatesWe are experts in developing in vitro 3D Human-derived Adipose Tissue and Heart Spheroids and Organoids. Our 3D human models are self-assembled and Matrigel-free, setting us apart from our competitors. Our 3D human models are morpho-functionally validated compared to classic 2D models widespread in drug discovery and development. In addition, we provide consulting in 3D technologies and confocal and high throughput microscope imaging focused on morphological and functional characterization of 3D models. OUR PORTFOLIO FOR ADIPOSE TISSUE INCLUDES: - Models derived from human adult cells. Stromal vascular fraction, SFV of both subcutaneous and visceral fat depots, the latter an exclusive product that sets us apart in the market. - Bonds Bio 3D human Adipose Tissue organoids in the most advanced platform to access mitochondrial respiration (OCR) and glycolysis (ECAR) (3D Seahorse plates - Seahorse, Agilent) ready to treat and read. - 2D-to-3D transition kits containing 96-well plates with 3D progenitor organoids and 96-well plates with 2D progenitor cells in a monolayer to run Bonds Bio Adipose Tissue differentiation protocol in parallel (Subcutaneous or Visceral). This transition kit is for you who need an extra layer of confidence before a complete transition to Bonds Bio 3D human mature organoids. We provide our organoids in 96- and 384-well plates, with individual organoids per well, an outstanding source of unique feature samples for your testing, allowing for mid-to-large scale analysis and compatible with the most common high-throughput systems available in the market. Our models are validated using cells from healthy donors (commercially available now) and Patient-Derived Organoids (PDOs) with samples from different ages, races, BMI index, and diseases (e.g., Type 2 diabetes, cancers). (For more information on our PDO line, contact us). COMING SOON… In addition to the human adult SVF-derived adipose tissue models, we are developing outstanding Adipose Tissue and Heart 3D human models derived from human-induced pluripotent stem cells (hiPSCs). We are now differentiating hiPSCs into subcutaneous, visceral, and beige-like adipocytes to assemble the next generation of Bonds Bio 3D human Adipose Tissue Organoids from hiPSCs. Last but not least, very soon, we will launch our hiPSC-derived Heart spheroids and Heart Organoids for you to test drugs cardiotoxicity and cardiovascular diseases in two outstanding platforms, more sensitive than their 2D peers and less complicated to handle than engineered-heart tissues (EHTs). Your heart will "beat faster" with Bonds Bio 3D Heart models (For more information on our Cardio line, contact us). ABOUT OUR COMPANY The development of human physiologically relevant 3D organoids is made more accessible with Bonds Biosystems. Our Mission is to turn INNOVATIVE science into more accurate and affordable therapies for patients worldwide through In VITRO 3D solutions, envisioning the creation of technologies that accelerate drug development, enhancing new therapies' efficacy to bring new HOPES to humankind, preferably reducing costs and reducing or even avoiding the need for animal models use. If you want to be a part of this revolution of in vitro biology, do not hesitate to contact us at bondsbio.com/contact We are looking forward to helping you to transform your 3D experience!
150 Huntington Ave Apt. SDL Boston, MA, 02115 United StatesWe are experts in developing in vitro 3D Human-derived Adipose Tissue and Heart Spheroids and Organoids. Our 3D human models are self-assembled and Matrigel-free, setting us apart from our competitors. Our 3D human models are morpho-functionally validated compared to classic 2D models widespread in drug discovery and development. In addition, we provide consulting in 3D technologies and confocal and high throughput microscope imaging focused on morphological and functional characterization of 3D models. OUR PORTFOLIO FOR ADIPOSE TISSUE INCLUDES: - Models derived from human adult cells. Stromal vascular fraction, SFV of both subcutaneous and visceral fat depots, the latter an exclusive product that sets us apart in the market. - Bonds Bio 3D human Adipose Tissue organoids in the most advanced platform to access mitochondrial respiration (OCR) and glycolysis (ECAR) (3D Seahorse plates - Seahorse, Agilent) ready to treat and read. - 2D-to-3D transition kits containing 96-well plates with 3D progenitor organoids and 96-well plates with 2D progenitor cells in a monolayer to run Bonds Bio Adipose Tissue differentiation protocol in parallel (Subcutaneous or Visceral). This transition kit is for you who need an extra layer of confidence before a complete transition to Bonds Bio 3D human mature organoids. We provide our organoids in 96- and 384-well plates, with individual organoids per well, an outstanding source of unique feature samples for your testing, allowing for mid-to-large scale analysis and compatible with the most common high-throughput systems available in the market. Our models are validated using cells from healthy donors (commercially available now) and Patient-Derived Organoids (PDOs) with samples from different ages, races, BMI index, and diseases (e.g., Type 2 diabetes, cancers). (For more information on our PDO line, contact us). COMING SOON… In addition to the human adult SVF-derived adipose tissue models, we are developing outstanding Adipose Tissue and Heart 3D human models derived from human-induced pluripotent stem cells (hiPSCs). We are now differentiating hiPSCs into subcutaneous, visceral, and beige-like adipocytes to assemble the next generation of Bonds Bio 3D human Adipose Tissue Organoids from hiPSCs. Last but not least, very soon, we will launch our hiPSC-derived Heart spheroids and Heart Organoids for you to test drugs cardiotoxicity and cardiovascular diseases in two outstanding platforms, more sensitive than their 2D peers and less complicated to handle than engineered-heart tissues (EHTs). Your heart will "beat faster" with Bonds Bio 3D Heart models (For more information on our Cardio line, contact us). ABOUT OUR COMPANY The development of human physiologically relevant 3D organoids is made more accessible with Bonds Biosystems. Our Mission is to turn INNOVATIVE science into more accurate and affordable therapies for patients worldwide through In VITRO 3D solutions, envisioning the creation of technologies that accelerate drug development, enhancing new therapies' efficacy to bring new HOPES to humankind, preferably reducing costs and reducing or even avoiding the need for animal models use. If you want to be a part of this revolution of in vitro biology, do not hesitate to contact us at bondsbio.com/contact We are looking forward to helping you to transform your 3D experience!
900 Ridgebury Road R&D 7313 Ridgefield, CT, 06877 United StatesWe are experts in developing in vitro 3D Human-derived Adipose Tissue and Heart Spheroids and Organoids. Our 3D human models are self-assembled and Matrigel-free, setting us apart from our competitors. Our 3D human models are morpho-functionally validated compared to classic 2D models widespread in drug discovery and development. In addition, we provide consulting in 3D technologies and confocal and high throughput microscope imaging focused on morphological and functional characterization of 3D models. OUR PORTFOLIO FOR ADIPOSE TISSUE INCLUDES: - Models derived from human adult cells. Stromal vascular fraction, SFV of both subcutaneous and visceral fat depots, the latter an exclusive product that sets us apart in the market. - Bonds Bio 3D human Adipose Tissue organoids in the most advanced platform to access mitochondrial respiration (OCR) and glycolysis (ECAR) (3D Seahorse plates - Seahorse, Agilent) ready to treat and read. - 2D-to-3D transition kits containing 96-well plates with 3D progenitor organoids and 96-well plates with 2D progenitor cells in a monolayer to run Bonds Bio Adipose Tissue differentiation protocol in parallel (Subcutaneous or Visceral). This transition kit is for you who need an extra layer of confidence before a complete transition to Bonds Bio 3D human mature organoids. We provide our organoids in 96- and 384-well plates, with individual organoids per well, an outstanding source of unique feature samples for your testing, allowing for mid-to-large scale analysis and compatible with the most common high-throughput systems available in the market. Our models are validated using cells from healthy donors (commercially available now) and Patient-Derived Organoids (PDOs) with samples from different ages, races, BMI index, and diseases (e.g., Type 2 diabetes, cancers). (For more information on our PDO line, contact us). COMING SOON… In addition to the human adult SVF-derived adipose tissue models, we are developing outstanding Adipose Tissue and Heart 3D human models derived from human-induced pluripotent stem cells (hiPSCs). We are now differentiating hiPSCs into subcutaneous, visceral, and beige-like adipocytes to assemble the next generation of Bonds Bio 3D human Adipose Tissue Organoids from hiPSCs. Last but not least, very soon, we will launch our hiPSC-derived Heart spheroids and Heart Organoids for you to test drugs cardiotoxicity and cardiovascular diseases in two outstanding platforms, more sensitive than their 2D peers and less complicated to handle than engineered-heart tissues (EHTs). Your heart will "beat faster" with Bonds Bio 3D Heart models (For more information on our Cardio line, contact us). ABOUT OUR COMPANY The development of human physiologically relevant 3D organoids is made more accessible with Bonds Biosystems. Our Mission is to turn INNOVATIVE science into more accurate and affordable therapies for patients worldwide through In VITRO 3D solutions, envisioning the creation of technologies that accelerate drug development, enhancing new therapies' efficacy to bring new HOPES to humankind, preferably reducing costs and reducing or even avoiding the need for animal models use. If you want to be a part of this revolution of in vitro biology, do not hesitate to contact us at bondsbio.com/contact We are looking forward to helping you to transform your 3D experience!
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.